Welcoming Dr. Sally Radovick
Dear colleagues,
I would like to extend a warm welcome to Sally Radovick, MD, the newest member of the University of Arizona Health Sciences executive leadership team. Dr. Radovick joins us as director of the developing Clinical and Translational Sciences Institute, where she will oversee a broad range of translational and clinical research programs at Health Sciences. In this role, she will direct the Clinical and Translational Science Research Center and serve as a leader of the All of Us Research Program University of Arizona-Banner Health.
Sally Radovick, MD
Dr. Radovick’s career accomplishments show she is a forward-thinking physician-scientist with experience in clinical care, a longstanding history of implementing successful clinical research programs and a strong ability to collaborate across disciplines. In her new position, she will expand our current infrastructure in clinical and translational research and support career development opportunities for trainees and junior faculty to advance the stature of Health Sciences.
Most recently, Dr. Radovick worked at Rutgers-Robert Wood Johnson Medical School, where she was the senior associate dean for clinical and translational research, and professor and chair of the Department of Pediatrics. Prior to that, she was the division director of pediatric endocrinology and the vice-chair for research in the Department of Pediatrics at Johns Hopkins University School of Medicine.
Dr. Radovick’s research focuses on the molecular mechanisms of human growth and reproduction. Her studies also reflect an interest in diabetes and metabolism. She has developed community-based diet and exercise programs for obese and overweight children associated with NIH-funded Diabetes Research and Training Centers at the University of Chicago and Johns Hopkins University. Her impressive record of federal funding includes awards as the principal investigator on multiple R01, U01 and center grants.
During her tenure at Rutgers, she implemented changes that increased the number of clinical research protocols by 50% and doubled the number of investigator-initiated protocols. Dr. Radovick also helped secure the state’s first National Institutes of Health Clinical and Translational Award Science Award, then helped establish strong collaborative cores between Rutgers Biological Health System, the New Jersey Institute of Technology and Princeton University. At Johns Hopkins she expanded institutional research by creating new NIH-funded multi-PI collaborations and securing new T32 training grant funding.
Dr. Radovick has a long history of serving as a valuable mentor to students, residents, fellows and junior faculty, and she regularly optimized opportunities to train and retain future faculty. Early in her career, she was an integral member of the Harvard Scientist Training Program and served on a committee that designed a novel curriculum for future physician-scientists.
As a clinical leader at Rutgers, she developed collaborations to promote patient care and increase clinical income. She doubled the number of faculty members in pediatrics, which resulted in a 50% increase in patient visits and a significant reduction in patient wait time for an appointment. Programs she instituted have improved the health of children and families, engaged community physicians and resulted in new endowments.
I am confident her background in research, academic administration, teaching and mentoring, and clinical care will be an asset to our organization and the university overall. Please join me in welcoming her to the University of Arizona Health Sciences.
Michael D. Dake, MD
Senior Vice President for University of Arizona Health Sciences